Aliko.Pa
ALIKO.PA operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
Business. ALIKO.PA operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
ALIKO.PA operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
ALIKO.PA exhibits a weak capital structure and liquidity position, with a current ratio of 0.2 and a debt-to-equity ratio of 0.14. The company's free cash flow is negative at -1,001,330 EUR, and operating cash flow is also negative at -914,220 EUR, indicating significant liquidity constraints.
Profitability metrics are severely negative, with a return on equity of -14.41% and a return on assets of -10.87%. These figures are well below the industry median for medical equipment and supplies, which typically shows positive returns. The company's net income is -2,267,650 EUR, and operating income is -2,193,730 EUR, reflecting a deep operational loss.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of segment and geographic diversification increases exposure to sector-specific risks.
Growth trajectory is negative, with no positive revenue growth indicators in the available data. The company's revenue for the latest period is 448,560 EUR, and there are no disclosed plans for future revenue expansion. Analysts have assigned a mean price target of 2.80 EUR, with no variance in estimates, suggesting limited upside potential.
Risk factors include medium liquidity risk and a negative cash flow position. The company has a low dilution risk, with no near-term pressure for additional equity issuance. However, the negative net cash position after subtracting total debt raises concerns about short-term solvency.
Recent events include the publication of the latest financial report, which discloses the company's significant losses and liquidity challenges. No recent earnings call transcripts or major regulatory filings are available in the provided data.
- ALIKO.PA is experiencing severe operational and financial losses, with negative returns on equity and assets.
- The company's liquidity position is weak, with a current ratio of 0.2 and negative free cash flow.
- Analysts have assigned a uniform price target of 2.80 EUR, indicating limited upside potential.
- The company lacks geographic and segment diversification, increasing exposure to sector-specific risks.
- There is no indication of near-term dilution pressure, but liquidity constraints remain a key concern.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,21 |
| Revenue | —no estimate | —no estimate | 1,0M EUR |
| Operating income | —no estimate | —no estimate | -2,0M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- ALIKO.PA Market data — financials · 2026-05-27
- Ikonisys SA Market data — analyst estimates · 2026-05-27